SCOPUS 정보 검색 플랫폼

Volumn 69, Issue SUPPL. 2, 2009, Pages

Development and validation of a stability-indicating LC method for determination of ebastine in tablet and syrup

(6) Arend, Marcela Z a Cardoso, Simone G b Hurtado, Felipe K a Ravanello, Aline a Lanzanova, Fibele A a Rolim, Clarice M B a

a FEDERAL UNIVERSITY OF SANTA MARIA (Brazil)

b FEDERAL UNIVERSITY OF SANTA CATARINA (Brazil)

Author keywords

Column liquid chromatography; Ebastine; Method validation; Stability indicating

Indexed keywords

ACETONITRILE; EBASTINE; PHOSPHORIC ACID;

ACCURACY; ANALYTIC METHOD; ARTICLE; DIODE ARRAY DETECTION; DRUG DEGRADATION; DRUG DETERMINATION; DRUG STABILITY; FLOW RATE; PRIORITY JOURNAL; REVERSED PHASE LIQUID CHROMATOGRAPHY; SYRUP; TABLET; ULTRAVIOLET SPECTROSCOPY; VALIDATION PROCESS; VALIDATION STUDY;

EID: 67651251781 PISSN: 00095893 EISSN: 16121112 Source Type: Journal
DOI: 10.1365/s10337-009-0992-4 Document Type: Article

Times cited : (11)

References (14)

1
- 0033429851
- 10.2165/00002018-199921001-00008
- X Luria 1999 Drug Saf 21 63 67 10.2165/00002018-199921001-00008
- (1999) Drug Saf , vol.21 , pp. 63-67
- Luria, X.¹

2
- 0027083606
- J Llupiá J Bou AG Fernández J Llenas J Puig P Berga R Massingham DJ Roberts 1992 Drugs Today Barc 28 11 21
- (1992) Drugs Today Barc , vol.28 , pp. 11-21
- Llupiá, J.¹ Bou, J.² Fernández, A.G.³ Llenas, J.⁴ Puig, J.⁵ Berga, P.⁶ Massingham, R.⁷ Roberts, D.J.⁸

3
- 0028216922
- 10.1254/fpj.103.121
- I Yakuo K Ishii Y Seto K Imano K Takeyama H Nakamura T Karasawa 1994 Folia Pharmacol Jpn 103 121 135 10.1254/fpj.103.121
- (1994) Folia Pharmacol Jpn , vol.103 , pp. 121-135
- Yakuo, I.¹ Ishii, K.² Seto, Y.³ Imano, K.⁴ Takeyama, K.⁵ Nakamura, H.⁶ Karasawa, T.⁷

4
- 0032977626
- 1 receptor antagonists
- DOI 10.2165/00003088-199936050-00003
- FER Simons KJ Simons 1999 Clin Pharmacokinet 36 329 352 10.2165/00003088-199936050-00003 (Pubitemid 29261510)
- (1999) Clinical Pharmacokinetics , vol.36 , Issue.5 , pp. 329-352
- Simons, F.E.R.¹ Simons, K.J.²

5
- 1442283864
- Pharmacokinetics and Safety of Ebastine in Patients with Impaired Hepatic Function Compared with Healthy Volunteers: A Phase I Open-Label Study
- DOI 10.2165/00003088-200443020-00004
- KC Lasseter SC Dilzer R Vargas S Waldman RJ Noveck 2004 Clin Pharmacokinet 43 121 129 10.2165/00003088-200443020-00004 (Pubitemid 38283134)
- (2004) Clinical Pharmacokinetics , vol.43 , Issue.2 , pp. 121-129
- Lasseter, K.C.¹ Dilzer, S.C.² Vargas, R.³ Waldman, S.⁴ Noveck, R.J.⁵

6
- 8844229574
- Simultaneous determination of ebastine and its three metabolites in plasma using liquid chromatography-tandem mass spectrometry
- DOI 10.1016/j.jchromb.2004.09.017, PII S1570023204007512
- W Kang KH Liu JY Ryu JG Shin 2004 J Chromatogr B Analyt Technol Biomed Life Sci 813 75 80 10.1016/j.jchromb.2004.09.017 (Pubitemid 39535431)
- (2004) Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences , vol.813 , Issue.1-2 , pp. 75-80
- Kang, W.¹ Liu, K.-H.² Ryu, J.-Y.³ Shin, J.-G.⁴

7
- 15244344403
- 1-antagonists ebastine and loratadine in healthy subjects: Pharmacokinetic and pharmacodynamic effects
- DOI 10.1111/j.1365-2125.2005.02348.x
- P Chaikin MS Gillen M Malik H Pentikis GR Rhodes DJ Roberts 2005 Br J Clin Pharmacol 59 346 354 10.1111/j.1365-2125.2005.02348.x (Pubitemid 40392499)
- (2005) British Journal of Clinical Pharmacology , vol.59 , Issue.3 , pp. 346-354
- Chaikin, P.¹ Gillen, M.S.² Malik, M.³ Pentikis, H.⁴ Rhodes, G.R.⁵ Roberts, D.J.⁶

8
- 0035811253
- 1-receptor antagonist ebastine and its two metabolites, carebastine and hydroxyebastine, in human plasma using high-performance liquid chromatography
- DOI 10.1016/S0378-4347(00)00494-1, PII S0378434700004941
- M Matsuda Y Mizuki Y Terauchi 2001 J Chromatogr B Analyt Technol Biomed Life Sci 757 173 179 10.1016/S0378-4347(00)00494-1 (Pubitemid 32424470)
- (2001) Journal of Chromatography B: Biomedical Sciences and Applications , vol.757 , Issue.1 , pp. 173-179
- Matsuda, M.¹ Mizuki, Y.² Terauchi, Y.³

9
- 34249742089
- Pharmacokinetics and safety of ebastine in healthy subjects and patients with renal impairment
- DOI 10.2165/00003088-200746060-00006
- RJ Noveck RA Preston SK Swan 2007 Clin Pharmacokinet 46 525 534 10.2165/00003088-200746060-00006 (Pubitemid 46827861)
- (2007) Clinical Pharmacokinetics , vol.46 , Issue.6 , pp. 525-534
- Noveck, R.J.¹ Preston, R.A.² Swan, S.K.³

10
- 10644277755
- PG Sunitha V Niraimathi A Aruna V Vaidhyalingam A Shantana 2003 Indian Drugs 40 390 392
- (2003) Indian Drugs , vol.40 , pp. 390-392
- Sunitha, P.G.¹ Niraimathi, V.² Aruna, A.³ Vaidhyalingam, V.⁴ Shantana, A.⁵

11
- 0038475892
- P Ashok SN Meyyanathan B Pandilla B Suresk 2003 J Plan Chromatogr-Modern TLC 16 167 169
- (2003) J Plan Chromatogr-Modern TLC , vol.16 , pp. 167-169
- Ashok, P.¹ Meyyanathan, S.N.² Pandilla, B.³ Suresk, B.⁴

12
- 10844273402
- PG Sunitha V Niraimathi A Aruna V Vaidhyalingam A Shantana 2003 Indian Drugs 40 577 579
- (2003) Indian Drugs , vol.40 , pp. 577-579
- Sunitha, P.G.¹ Niraimathi, V.² Aruna, A.³ Vaidhyalingam, V.⁴ Shantana, A.⁵

13
- 52149093063
- SL Prabu CD Kumar A Shirwaikar A Shirwaikar 2008 Indian J Pharm Sci 70 406 407
- (2008) Indian J Pharm Sci , vol.70 , pp. 406-407
- Prabu, S.L.¹ Kumar, C.D.² Shirwaikar, A.³ Shirwaikar, A.⁴

14
- 34547625365
- Validation of analytical procedures: Text and methodology Q2(R1)
- International Conference on Harmonisation (ICH) of Technical Requirements for the Registration of Pharmaceutical for Human Use (2005) Validation of analytical procedures: text and methodology Q2(R1)
- (2005) International Conference on Harmonisation (ICH) of Technical Requirements for the Registration of Pharmaceutical for Human Use

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.